WASHINGTON (AP) — The Food and Drug Administration is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart […]
SAN FRANCISCO (AP) — A multibillion dollar case between two giant pharmaceutical companies grappling over arcane antitrust issues has unexpectedly turned into a gay rights legal imbroglio that raises questions over whether lawyers can bounce […]
WASHINGTON (AP) — A former blockbuster diabetes pill which was subjected to major safety restrictions in 2010 may not be as risky as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug […]
WASHINGTON (AP) — A panel of respiratory experts has voted in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravence for treating chronic lung disease.
LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu. The drug […]
WASHINGTON (AP) – More Americans than ever are taking generic drugs, as blockbuster medicines like Plavix and Lipitor become available in low-cost versions. But the government’s revelation this week that it mistakenly approved a defective […]
TRENTON, N.J. (AP) – Pharmaceutical industry heavyweights are teaming up to address a challenge that’s long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, […]